⌘K
Loading ticker…
Cartesian Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Cartesian Therapeutics, Inc. Common Stock (RNAC) has a 3-month relative strength percentile of 91 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 13.9%, relative volume 1.62×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 91, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RNAC is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional. Top 3 carry $4M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| IWMiShares Russell 2000 ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $703K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $98K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RNAC Jan avg: 2.33% median: 4.44% win: 67% σ: 6.79% n: 3 2023-11-15 → 2026-05-29 | RNAC Feb avg: 3.43% median: 1.60% win: 67% σ: 6.96% n: 3 2023-11-15 → 2026-05-29 | RNAC Mar avg: -20.05% median: -18.97% win: 0% σ: 9.50% n: 3 2023-11-15 → 2026-05-29 | RNAC Apr avg: 1.79% median: 1.14% win: 67% σ: 11.08% n: 3 2023-11-15 → 2026-05-29 | RNAC May avg: 19.40% median: 21.22% win: 67% σ: 38.86% n: 3 2023-11-15 → 2026-05-29 | RNAC Jun avg: -6.76% median: -6.76% win: 50% σ: 21.84% n: 2 2023-11-15 → 2026-05-29 (current) | RNAC Jul avg: -8.18% median: -8.18% win: 50% σ: 44.51% n: 2 2023-11-15 → 2026-05-29 | RNAC Aug avg: -17.95% median: -17.95% win: 0% σ: 5.08% n: 2 2023-11-15 → 2026-05-29 | RNAC Sep avg: 8.58% median: 8.58% win: 100% σ: 9.74% n: 2 2023-11-15 → 2026-05-29 | RNAC Oct avg: 1.39% median: 1.39% win: 50% σ: 30.33% n: 2 2023-11-15 → 2026-05-29 | RNAC Nov avg: 4.32% median: -4.90% win: 33% σ: 19.00% n: 3 2023-11-15 → 2026-05-29 | RNAC Dec avg: -2.16% median: -3.74% win: 33% σ: 3.77% n: 3 2023-11-15 → 2026-05-29 |